Dov A MD Goldstein is a director of Coya Therapeutics Inc.
Person profile
Roles
Employees
Incorporated
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Coya Therapeutics, Inc.
4 Jan 23
3
Coya Therapeutics, Inc.
28 Dec 22
4
Gain Therapeutics, Inc.
22 Sep 22
4
NeuBase Therapeutics, Inc.
12 Sep 22
4
NeuBase Therapeutics, Inc.
17 Sep 21
4
NeuBase Therapeutics, Inc.
21 Jun 21
4
NeuBase Therapeutics, Inc.
27 Apr 21
3
Gain Therapeutics, Inc.
17 Mar 21
4
NeuBase Therapeutics, Inc.
11 Sep 20
4
NeuBase Therapeutics, Inc.
4 May 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 23 | COYA Coya Therapeutics | Common Stock, par value $0.0001 per share | Buy | Acquire P | No | No | 0 | 10,000 | 0.00 | 10,000 |
| 3 Jan 23 | COYA Coya Therapeutics | Warrant to Purchase Common Stock Common Stock, par value $0.0001 per share | Buy | Acquire P | No | No | 7.5 | 5,000 | 37.50 k | 5,000 |
| 20 Sep 22 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 10,500 | 36.75 k | 10,500 |
| 9 Sep 22 | NBSE NeuBase Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 0.6 | 37,600 | 22.56 k | 37,600 |